Adamantan-1-yl(phenyl)methanamine is primarily used in the development of pharmaceutical compounds due to its unique structural properties. Its adamantane moiety provides stability and lipophilicity, making it valuable in drug design, particularly for central nervous system (CNS) targeting. It has been explored as a potential building block for synthesizing antiviral and neuroprotective agents, leveraging its ability to cross the blood-brain barrier. Additionally, its phenyl group allows for modifications that can enhance binding affinity to specific biological targets, making it useful in the creation of receptor modulators or enzyme inhibitors. Research has also investigated its role in developing treatments for neurodegenerative diseases like Alzheimer's, where its structural features may help in reducing amyloid plaque formation.